logo
#

Latest news with #Fortis

A $7,000 TFSA Strategy That Focuses on Dividend Growth
A $7,000 TFSA Strategy That Focuses on Dividend Growth

Yahoo

time2 days ago

  • Business
  • Yahoo

A $7,000 TFSA Strategy That Focuses on Dividend Growth

Written by Andrew Walker at The Motley Fool Canada Retirees and other dividend investors are searching for ways to get better returns on savings held inside a self-directed Tax-Free Savings Account (TFSA). One popular investing strategy involves buying good dividend-growth stocks that can provide income and boost long-term gains. The TFSA limit in 2025 is $7,000. All interest, dividends, and capital gains generated inside a TFSA on qualifying investments are tax-free. This means the full value of the earnings can go right into your pocket without having to share some with the CRA. The gains can also be fully reinvested, if passive income isn't the core goal. Retirees who receive Old Age Security (OAS) get another benefit. The CRA does not count TFSA income when calculating net world income used to determine the Old Age Security (OAS) pension recovery tax. This is important for seniors with high incomes. Every dollar of net world income earned above a minimum threshold triggers a $0.15 pension recovery tax. The number to watch in the 2025 tax year is $93,454. As such, retirees should consider fully using TFSA contribution space before holding income-generating investments inside taxable accounts. Younger investors can use dividend stocks to build retirement savings inside a TFSA. One strategy involves owning dividend-growth stocks and reinvesting the distributions in new shares. This sets off a powerful compounding process that can turn modest initial investments into meaningful savings over time, especially when dividends increase and the share price drifts higher. Fortis (TSX:FTS) is a good example of a stock with a great track record of dividend growth. The company has raised the payout in each of the past 51 years. Fortis operates utility businesses in Canada, the United States, and the Caribbean. The company has $75 billion in assets, including natural gas utilities, power generation facilities, and electric transmission networks. Nearly all of the revenue comes from rate-regulated businesses. This means cash flow is normally predictable and reliable. Fortis is working on a $26 billion capital program that will raise the rate base from $39 billion in 2024 to $53 billion in 2029. Revenue and earnings growth from the new assets should support planned annual dividend increases of 4% to 6% over the next five years. New projects are under consideration that could get added to the backlog. This would potentially extend the dividend-growth guidance or boost the size of the increases. Fortis has a dividend reinvestment plan that gives investors a 2% discount on stock purchased using dividend distributions. On the risk side, Fortis is sensitive to changes in interest rates due to the large amount of debt it uses to fund part of the capital program. The stock fell when the central banks in Canada and the United States raised rates in 2022. Rate cuts last year spurred the rebound. Analysts broadly expect interest rates to continue to decline later this year, as long as there isn't a spike in inflation caused by tariffs. Buying Fortis on pullbacks has historically proven to be a savvy move for patient investors. The TSX is home to many good dividend-growth stocks that investors can own to generate income and long-term total returns inside a self-directed TFSA. Fortis still deserves to be on your radar, even after the nice rally in the past year. The post A $7,000 TFSA Strategy That Focuses on Dividend Growth appeared first on The Motley Fool Canada. Before you buy stock in Fortis, consider this: The Motley Fool Stock Advisor Canada analyst team just identified what they believe are the Top Stocks for 2025 and Beyond for investors to buy now… and Fortis wasn't one of them. The Top Stocks that made the cut could potentially produce monster returns in the coming years. Consider MercadoLibre, which we first recommended on January 8, 2014 ... if you invested $1,000 in the 'eBay of Latin America' at the time of our recommendation, you'd have $21,345.77!* Stock Advisor Canada provides investors with an easy-to-follow blueprint for success, including guidance on building a portfolio, regular updates from analysts, and two new stock picks each month – one from Canada and one from the U.S. The Stock Advisor Canada service has outperformed the return of S&P/TSX Composite Index by 24 percentage points since 2013*. See the Top Stocks * Returns as of 4/21/25 More reading Made in Canada: 5 Homegrown Stocks Ready for the 'Buy Local' Revolution [PREMIUM PICKS] Market Volatility Toolkit Best Canadian Stocks to Buy in 2025 Beginner Investors: 4 Top Canadian Stocks to Buy for 2025 5 Years From Now, You'll Probably Wish You Grabbed These Stocks Subscribe to Motley Fool Canada on YouTube The Motley Fool recommends Fortis. The Motley Fool has a disclosure policy. Fool contributor Andrew Walker has no position in any stock mentioned. 2025 Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

Is Fortis Stock a Buy Now?
Is Fortis Stock a Buy Now?

Yahoo

time3 days ago

  • Business
  • Yahoo

Is Fortis Stock a Buy Now?

Written by Andrew Walker at The Motley Fool Canada Fortis (TSX:FTS) is up nearly 18% in the past year. Investors who missed the rally are wondering if FTS stock is still undervalued and good to buy for a self-directed Tax-Free Savings Account (TFSA) or Registered Retirement Savings Plan (RRSP) portfolio focused on dividends and total returns. Fortis trades near $65.50 at the time of writing. The stock has been on an upward trend for most of the past 12 months, spurred by cuts to interest rates in Canada and the United States. The rebound occurred after the stock had fallen from near $65 in the spring of 2022 to as low as $50 in October that year as the central banks ramped up rate hikes to cool off a hot economy and get inflation under control. Utility companies use a lot of debt to fund large capital projects that can cost billions of dollars and take years to complete. As such, they are sensitive to changes in interest rates. Higher rates drive up borrowing expenses, which puts pressure on profits and can reduce cash available for distribution to shareholders. Elevated debt costs can also force companies to shelve some projects. The U.S. Federal Reserve and the Bank of Canada cut rates over the past year, but are currently on hold as they wait to see how tariffs will impact the economy and inflation. If inflation jumps in the coming months, the central banks will have a tough time justifying additional rate cuts. In fact, rate hikes might be needed. In that scenario, Fortis could face new headwinds. That being said, analysts widely expect economic weakness to push the central banks to cut rates again before the end of the year, even if inflation drifts higher. Falling rates would be positive for Fortis and other utility stocks. Fortis is working on a $26 billion capital program that will raise the rate base from $39 billion in 2024 to $53 billion in 2029. As the new assets are completed and go into service, Fortis expects earnings to rise enough to support annual dividend increases of 4% to 6% over the five years. Fortis raised the dividend in each of the past 51 years, so investors should feel comfortable with the guidance. At the time of writing, the stock provides a dividend yield of 3.8%. Management has other projects under consideration that could get added to the development plan. Fortis also has a strong track record of making strategic acquisitions. Falling interest rates could spur a wave of consolidation in the utility sector. Near-term volatility should be expected until there is more clarity on a trade agreement between Canada and the United States, as well as between the U.S. and its other major trading partners. Fortis is down, however, from the recent high around $69, so investors now have a chance to buy the stock on a nice dip. Acquiring FTS stock on pullbacks has historically proven to be a savvy move for patient investors focused on passive income and long-term capital gains. The post Is Fortis Stock a Buy Now? appeared first on The Motley Fool Canada. Before you buy stock in Fortis, consider this: The Motley Fool Stock Advisor Canada analyst team just identified what they believe are the Top Stocks for 2025 and Beyond for investors to buy now… and Fortis wasn't one of them. The Top Stocks that made the cut could potentially produce monster returns in the coming years. Consider MercadoLibre, which we first recommended on January 8, 2014 ... if you invested $1,000 in the 'eBay of Latin America' at the time of our recommendation, you'd have $21,345.77!* Stock Advisor Canada provides investors with an easy-to-follow blueprint for success, including guidance on building a portfolio, regular updates from analysts, and two new stock picks each month – one from Canada and one from the U.S. The Stock Advisor Canada service has outperformed the return of S&P/TSX Composite Index by 24 percentage points since 2013*. See the Top Stocks * Returns as of 4/21/25 More reading Made in Canada: 5 Homegrown Stocks Ready for the 'Buy Local' Revolution [PREMIUM PICKS] Market Volatility Toolkit Best Canadian Stocks to Buy in 2025 Beginner Investors: 4 Top Canadian Stocks to Buy for 2025 5 Years From Now, You'll Probably Wish You Grabbed These Stocks Subscribe to Motley Fool Canada on YouTube Fool contributor Andrew Walker has no position in any stock mentioned. The Motley Fool recommends Fortis. The Motley Fool has a disclosure policy. 2025 Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

Fortis Inc. Announces Results of Series H First Preference Share and Series I Preference Share Conversions
Fortis Inc. Announces Results of Series H First Preference Share and Series I Preference Share Conversions

Yahoo

time7 days ago

  • Business
  • Yahoo

Fortis Inc. Announces Results of Series H First Preference Share and Series I Preference Share Conversions

ST. JOHN'S, Newfoundland and Labrador, June 02, 2025 (GLOBE NEWSWIRE) -- Fortis Inc. ("Fortis" or the "Corporation") (TSX: FTS) announced today that 11,298 of its 7,665,082 issued and outstanding Cumulative Redeemable Five-Year Fixed Rate Reset First Preference Shares, Series H ("Series H Shares") were tendered for conversion, on a one-for-one basis, into Cumulative Redeemable Floating Rate First Preference Shares, Series I ("Series I Shares") and that 248,830 of its 2,334,918 Series I Shares were tendered for conversion, on a one-for-one basis, into Series H Shares. As a result of the conversion, Fortis has 7,902,614 Series H Shares and 2,097,386 Series I Shares issued and outstanding. The Series H Shares and the Series I Shares will continue to be listed on the Toronto Stock Exchange ("TSX") under the symbols and respectively. The Series H Shares will pay on a quarterly basis, for the five-year period beginning on June 1, 2025, if, as and when declared by the Board of Directors of Fortis, a fixed dividend based on an annual fixed dividend rate of 4.183 percent. The Series I Shares will pay a floating quarterly dividend for the five-year period beginning on June 1, 2025, if, as and when declared by the Board of Directors of Fortis. The floating quarterly dividend rate for the Series I Shares for the first quarterly floating rate period (being the period from and including June 1, 2025 and ending on and including August 31, 2025) is based on an annual floating dividend rate of 4.103 percent and will be reset every quarter based on the applicable three-month Government of Canada Treasury Bill rate plus 1.450 percent. For more information on the terms of, and risks associated with an investment in, the Series H Shares and the Series I Shares, please see the Corporation's short form prospectus dated January 18, 2010 relating to the issuance of the Series H Shares, which can be found under the Corporation's profile on SEDAR+ at and on the Corporation's website at About Fortis Fortis is a well-diversified leader in the North American regulated electric and gas utility industry, with 2024 revenue of $12 billion and total assets of $75 billion as at March 31, 2025. The Corporation's 9,800 employees serve utility customers in five Canadian provinces, ten U.S. states and three Caribbean countries. Fortis shares are listed on the TSX and NYSE and trade under the symbol FTS. Additional information can be accessed at or A .pdf version of this press release is available at: For more information, please contact: Investor Enquiries:Ms. Stephanie Amaimo Vice President, Investor RelationsFortis Inc.248.946.3572investorrelations@ Media Enquiries:Ms. Karen McCarthyVice President, Communications & Government RelationsFortis Inc.709.737.5323media@ in to access your portfolio

Kolkata nurse gets Florence Nightingale award from Prez
Kolkata nurse gets Florence Nightingale award from Prez

Time of India

time31-05-2025

  • Health
  • Time of India

Kolkata nurse gets Florence Nightingale award from Prez

1 2 3 Kolkata: Doli Biswas, a nurse at a private hospital in Kolkata, received the prestigious National Florence Nightingale Award for her 'exemplary contribution to nursing and compassionate patient care'. She received the award from President Droupadi Murmu at Rashtrapati Bhavan on Friday. Biswas is the chief nursing officer at Fortis Hospital, Anandapur. The award is instituted by the ministry of health and family welfare. This prestigious recognition is presented to nursing professionals across the country for their outstanding dedication, service, and contributions to healthcare. Speaking on the honour, Biswas said: "Nursing is a noble service. Being recognised with the National Florence Nightingale Award is a great honour. It energises me to continue serving with empathy, integrity, and dedication. I am grateful to Fortis Hospital for supporting my journey and to the ministry." Fortis Healthcare congratulated Biswas on this exceptional achievement and remains committed to empowering and celebrating the nursing community at the heart of patient care. "This moment stands as a proud milestone not just for Biswas, but for the entire Fortis family. Her recognition serves as a reflection of the hospital's deep-rooted values in clinical excellence and its commitment to nurturing healthcare professionals who go above and beyond in service to the community," said a hospital spokesperson.

All big hospitals in city to come under Ayushman scheme, says Delhi Govt
All big hospitals in city to come under Ayushman scheme, says Delhi Govt

Indian Express

time30-05-2025

  • Health
  • Indian Express

All big hospitals in city to come under Ayushman scheme, says Delhi Govt

All the 'big hospitals' of Delhi will now be brought under the Ayushman Bharat insurance umbrella in the next '20-25 days', Health Minister Pankaj Singh told The Indian Express as the Rekha Gupta-led BJP government in the Capital completed 100 days in power Friday. Singh's remarks are significant because major private hospital groups in Delhi, such as Max, Fortis and Apollo, have not yet come on board the Ayushman Bharat Pradhan Mantri Jan Arogya Yojana (PMJAY) — the scheme's dashboard currently includes 82 other private hospitals, apart from 11 government facilities. According to Singh, private hospitals in Delhi were hesitant to sign up because the previous AAP government did not clear pending payments under other schemes. 'They did not make the payment on time from Delhi Arogya Nidhi (the financial assistance scheme run by the Directorate General of Health Services). Now I ensure that in the next 20-25 days, all the big hospitals will be empanelled under Ayushman Bharat. I will talk to them soon,' the Health Minister said. Under Ayushman Bharat PMJAY, patients from poor households get health insurance of up to Rs 5 lakh, and Rs 5 lakh for patients above the age of 70. While Centre offers a cover of Rs 5 lakh, Chief Minister Rekha Gupta had said after her Cabinet's first meeting that the Delhi government would provide an additional top-up of Rs 5 lakh to beneficiaries. Records show that more than 3.16 lakh beneficiaries have been registered so far from poor households, and 30,000 above the age of 70. Beneficiaries for the scheme are selected on the basis of National Food Security Act (NFSA) data, and Socio Economic and Caste Census 2011. So far, 601 beneficiaries have availed services under the scheme, Singh said. Healthcare representatives in Delhi, however, have called for a 'reality check' before the scheme is expanded. Currently, of 62 private hospitals under Ayushman Bharat for which details are publicly available, nine are eyecare facilities while others offer services related to general medicine, general surgery, obstetrics and gynaecology, and cardiology. Representing the Association of Healthcare Providers India (APHI), Dr Vipender Sabherwal, convenor for Ayushman Bharat, said, 'We have been in touch with the Union Health Ministry and government officials on pricing and rates, which do not match the requirements of good hospitals with all facilities. The amount being offered is meagre and not practical. Even our payments were not made on time under Ayushman Bharat.' Sabherwal said doctors' associations would get in touch with the Delhi government for further discussions. AHPI represents about 15,000 private hospitals, including Fortis, Max Healthcare, Manipal, Medanta, Narayana and Apollo. Meanwhile, the Delhi government is expected to launch 33 Jan Arogya Mandirs in place of AAP's mohalla clinics and government dispensaries on Saturday under the Centre's Pradhan Mantri Ayushman Bharat Health Infrastructure Mission scheme (PM-ABHIM). Health Minister Singh had earlier said the government would open 200 such centres. Each Arogya Mandir is expected to provide 12 service packages, including maternal and child healthcare, vaccinations, mental health services, elderly care, and treatment for communicable diseases. Each facility is mandated to maintain an essential drug list of 256 medicines, with in-house tests for blood sugar, haemoglobin, blood group, urine and pregnancy, among others — 90 other tests will be outsourced to Agilus Lab.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store